FindTrial
Sign In

Cancelled by the investigator Influence of nasal high-fow preoxygenation on video laryngoscope for emergency intubation in patients with critical novel coronavirus pneumonia (COVID-19)

Influence of nasal high-fow preoxygenation on video laryngoscope for emergency intubation in patients with critical novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030465
Enrollment
Unknown
Registered
2020-03-02
Start date
2020-03-02
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Group 2:SMO Assisted tracheal intubation
Group 1:Assisted tracheal intubation via nasal high-flow oxygen inhalation

Sponsors

The First Affiliated Hospital of Guangzhou University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Eligible patients were adults ((aged 18-80 years); 2. Were identified as laboratory-confirmed COVID-19 infection; 3. Those who need intubation in ICU, and with no severe hypoxemia.

Exclusion criteria

Exclusion criteria: 1. Intubation required immidiately in case of cardiac arrest or asphyxia; 2. Pregnancy, severe chronic respiratory, uncontrolled gastric reflux disease and any nasopharyngeal anatomical obstacle; 3. Those patients has intubated in ICU.

Design outcomes

Primary

MeasureTime frame
SpO2 during intubation;the total time of intubation;Mask ventilation for SpO2 < 90%;—

Secondary

MeasureTime frame
the incidence of hypoxia;the times of intubation;7-day mortality;—

Countries

China

Contacts

Public ContactWu Caineng

The First Affiliated Hospital of Guangzhou University of TCM

wucaineng861010@163.com+86 13580315308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026